Epstein Secrets

BMGF in October 2007 and bgC3 in April 2010. Dr. Nikolic has led select for-profit and not-for-profit investment activities at the aforementioned Gates-affiliated organizations. On the for-profit side, Dr. Nikolic has led investments in various life- science/IT/healthcare companies such as Foundation

led investments in various life- science/IT/healthcare companies such as Foundation Medicine and Research Gate, served on the board of directors of Schrodinger, and monitored Nimbus. On the not-for-profit side, Dr. Nikolic co- managed BMGF's $1.5 billion strategic-investment pool, focused on program-related

oximately $5.4 million grant from Bill & Melinda Gates Foundation (Cony D'Cruz; Richard Friesner) • Up

o Attachment 2: Proposed stock option awards 4. Exhibit B to Attachment 2: Amended and Restated License and Software Development Agreement between Schrodinger, LLC and D.L. Shaw Research, LLC 5. Attachment 3: Financial Statements for Q I, FY 2013 6. Attachment 4: Financial Presentation If you have any ue

ed and a full discussion followed. Mr. Friesner summarized his conversation with Bill Gates in December 2013 on a possible future financing by Mr. Gates. Mr. Guidero stated he would consult with Mr. Gates regarding the potential financing. The Board agreed to address the issue of whether additional

(by phone) 1. Call to Order. A meeting of the Board of Directors of Schrodinger, Inc. (the "Board"), a Delaware corporation, (the "Company" or "Schrodinger") was held at the above place and time. Mr. Ardai, presiding as Chairman of the meeting, conducted a roll call and confirmed that Mr. Nikolic, Mr.

people put money away for a rainy day. While Bill Gates and Warren Buffet have shown extraordinary benev

intuitively wrong. In most of the things that humans count, more is better, while with entropy less is normally better. In later sections I follow Schrodinger in using the concept of 'negentropy' (negative-entropy) to get round this problem. The important point of the energy/information debate is that the

Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gates Foundation (BMGF). Boris has led investment activities at these Gates-affiliated organizations on both the for-profit and non-for-profit aspects of Bill Gates' activities. On the for-profit side, Boris led investments

activities. On the for-profit side, Boris led investments in various life science/health care companies such as Foundation Medicine, Research Gate, Schrodinger and Nimbus through Bill Gates Ventures. On the non-for profit side, Boris co-managed BMGF's $1.5 billion strategic investment pool focused on progr